Stay updated on Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now shows 'Results Submitted' in the Results section, replacing 'No Results Posted'. This indicates that trial results are in progress and awaiting posting.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision: v3.4.2 has been added, and the funding-lapse notice along with Revision: v3.4.1 have been removed.SummaryDifference0.5%

- Check56 days agoChange DetectedA site-wide funding notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded a Show glossary toggle and updated metadata labels (changing 'Last Update met QC Criteria' to 'Last Update Submitted that Met QC Criteria' and standardizing 'No FEAR Act Data'), and updated the site revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.